Lv715
3230 积分 2021-05-31 加入
Biologic Therapies for Severe Asthma
1天前
待确认
Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study
11天前
已完结
Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial
17天前
已完结
Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial
18天前
已完结
Effect of depemokimab on asthma control and clinical outcomes: a systematic review and meta-analysis of randomized controlled trials
25天前
已完结
Switching to twice-yearly depemokimab from mepolizumab/benralizumab in severe asthma: A multicenter, randomized, double-blind, Phase 3A Clinical Trial (NIMBLE)
25天前
已完结
The preclinical discovery and development of depemokimab for severe eosinophilic asthma
25天前
已完结
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial
30天前
已完结
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype
30天前
已完结
Biologics for COPD — Finally Here
1个月前
已完结
皖公网安备34019202002308
